Systemic anti-CD20 (rituximab) as primary treatment for symptomatic primary uveal lymphoma

PURPOSE: Uveal lymphomas are indolent, frequently choroid-involving neoplasms that are mainly CD20-positive B-cell extranodal marginal zone lymphoma. Irreversible visual loss may occur from retinal detachment and/or glaucoma among untreated symptomatic patients, or from radiation-induced changes sec...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiu Teo, Honeylen Maryl, Çiftçi, Süleyman, Elner, Victor Maurice, Demirci, Hakan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586989/
https://www.ncbi.nlm.nih.gov/pubmed/31249903
http://dx.doi.org/10.1016/j.ajoc.2019.100484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586989/
https://www.ncbi.nlm.nih.gov/pubmed/31249903
http://dx.doi.org/10.1016/j.ajoc.2019.100484

Ejemplares similares